Pharma Mar, S.A.
PHMMF News Today: Stay Updated with the Latest Pharma Mar, S.A. News in Real Time
Find PHMMF news now at Meyka AI. Stay informed with the latest Pharma Mar, S.A. stocks updates, including price news, market analysis, and expert insights.
XtalPi Holdings Ltd Slips 3.3% as AI Drug Discovery Faces Valuation Pressure
2228.HK stock drops 3.3% to HK$7.9 amid sector headwinds. XtalPi Holdings faces valuation challenges despite AI-driven drug discovery focus.
Bristol-Myers Squibb Stock Drops 4.4% on Valuation Pressure
BMY.SW stock falls 4.4% to CHF42.54 on SIX. Pharma giant faces valuation headwinds despite strong dividend yield and upcoming earnings.
Eli Lilly Stock Surges 10.2% on Strong Earnings Growth and Pharma Momentum
LLY.SW stock jumps 10.2% to CHF755 on SIX. Eli Lilly reports strong earnings growth and maintains healthcare sector leadership with robust pipeline.
NSRX Insider Trade: CFO Rubin Eyal Options Filing May 20, 2026
Nasus Pharma CFO Rubin Eyal files initial ownership of 40,549 share options worth $306,550. Form 3 filing reveals executive equity stake.
Addex Therapeutics Ltd Slips 5% as Earnings Loom on SIX
ADXN.SW stock drops 5.06% to CHF0.045 ahead of May 25 earnings. Biotech firm faces profitability challenges.
Zydus Lifesciences Ltd Jumps 6.49% After Q4 Profit Rises 14.6% to ₹1,592.9 Crore
Zydus Lifesciences Ltd shares surged 6.49 percent after reporting a 14.6 percent rise in Q4 profit to ₹1,592.9 crore, driven by steady domestic and US market performance, with trading volumes rising nearly 28 percent in a single session as investors reacted to strong quarterly earnings and stable margins. Zydus Lifesciences Ltd Q4 stock impact and…
Gland Pharma Limited Surges 20.8% on Strong Volume Momentum
GLAND.BO stock jumps 20.8% with 201,296 shares traded. Pharma giant gains on strong technical signals and market recovery.
RADX Chief Medical Officer Voliotis Acquires 7.66M Options May 19, 2026
RADX insider Voliotis Dimitris acquires 7.66M options worth $191K. CMO’s Form 3 filing signals confidence in Radiopharm Theranostics.
RFBL Flexi Pack GMP Signals Positive Debut Before ₹52.50 NSE Opening
RFBL Flexi Pack is set to debut on the NSE SME platform on May 19, 2026, and early market signals are already drawing investor attention. The company’s IPO saw strong demand from institutional and retail investors, while the Grey Market Premium (GMP) hinted at a positive listing near ₹52.50. As India’s packaging industry continues to…